The Corrona Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, now includes more than 1,000 patients from 100 sites.

Dermatologists assess registry patients every six months during routine visits and fill out a comprehensive questionnaire. Patients participating in the registry are tracked for at least eight years, and the information collected will be used by researchers to compare the safety and effectiveness of psoriasis treatments, study diseases associated with psoriasis, and better understand the natural history of the disease. 

"The achievement of these milestones demonstrates the potential impact of this unique resource for the psoriasis community, providing us with real world data on novel psoriasis treatments," says Mark Lebwohl, MD, scientific co-director of the Corrona Psoriasis Registry, and chairman emeritus of the NPF Medical Board, in a news release.

Going forward, Corrona expects to add more than 200 dermatology sites to the network of sites. Interested dermatologists can email psoriasis@corrona.org for more information.